DASA Offering Natera's Panorama NIPD in Brazil | GenomeWeb

NEW YORK (GenomeWeb News) – DASA Group and Natera have reached a deal to offer Natera's non-invasive prenatal diagnostic test in Brazil, the companies announced on Thursday.

Financial and other terms were not disclosed.

Called Panorama, Natera's test detects trisomy 21, 18, and 13 and monosomy X with a simple blood draw from the mother. Panorama was launched in December.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.